| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 4 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.78M | $1.68M | - | |
| 10% | 4.78M | $1.68M | - | |
| Dir | 377.2K | $132.4K | -173,515 | |
| 10% | 361.2K | $126.8K | -678,226 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | Asanuma Sakae | Director, 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +17.8% | +3.3% | -66.7% |